Jinhai Medical Technology (HKSE:02225) COGS-to-Revenue : 0.79 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Jinhai Medical Technology COGS-to-Revenue?

Jinhai Medical Technology's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$156.4 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$197.3 Mil.

Jinhai Medical Technology's COGS to Revenue for the six months ended in Dec. 2023 was 0.79.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Jinhai Medical Technology's Gross Margin % for the six months ended in Dec. 2023 was 20.74%.

Jinhai Medical Technology COGS-to-Revenue Historical Data

The historical data trend for Jinhai Medical Technology's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhai Medical Technology COGS-to-Revenue Chart

Jinhai Medical Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.76

0.61

0.65

0.55

0.74

Jinhai Medical Technology Semi-Annual Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial												0.60	0.66	0.33	0.58	0.79

Jinhai Medical Technology COGS-to-Revenue Calculation

Jinhai Medical Technology's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	197.077	/	267.6
	=	0.74

Jinhai Medical Technology's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	156.419	/	197.347
	=	0.79

Jinhai Medical Technology (HKSE:02225) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Jinhai Medical Technology's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	156.419 / 197.347
	=	20.74 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Jinhai Medical Technology COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jinhai Medical Technology's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhai Medical Technology (HKSE:02225) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Jinhai Medical Technology Ltd (HKSE:02225) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

31 Sungei Kadut Avenue, Singapore, SGP, 729660

Website

https://www.jin-hai.com.hk

Jinhai International Group Holdings Ltd is a Singapore-based company engaged in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services, IT services, and construction ancillary services including warehousing services, cleaning services, and building maintenance work in Singapore. It earns a vast majority of its revenues from the Manpower outsourcing and ancillary services segment.

Executives

Liu Lei	2101 Beneficial owner
Chen Guobao	2201 Interest of corporation controlled by you
Full Fortune International Co., Ltd.	2101 Beneficial owner
Jiang Xiahong	2202 Interest of your spouse

Jinhai Medical Technology (HKSE:02225) Headlines

No Headlines